Results 211 to 220 of about 912,627 (390)
Entire spinal canal stenosis in lumbar cancel stenosis.
Kazuhiro Sakai +5 more
openalex +2 more sources
Sphingolipids are vital components of cell membranes. Metabolic disruptions of sphingolipids, including ceramide and sphingosine‐1‐phosphate, are linked to neurological disorders. This article summarizes the classification, structure, and metabolic processes of sphingolipids, and the physiological and pathological effects of sphingolipid metabolism and
Tian Li +7 more
wiley +1 more source
Which lumbar spinal stenosis patients will improve with nonsurgical treatment? A secondary analysis of a randomized controlled trial. [PDF]
Roseen EJ +11 more
europepmc +1 more source
Contribution of neuromuscular Impairment to physical functional Status in Patients with Lumbar Spinal Stenosis [PDF]
Fossel, Anne H. +4 more
core
Abstract Aims This study aimed to evaluate the efficacy and safety of triple therapy with lobeglitazone 0.5 mg as an add‐on treatment compared with placebo in patients with type 2 diabetes mellitus (T2DM) inadequately controlled with metformin and empagliflozin.
Da Hea Seo +8 more
wiley +1 more source
Degenerative lumbar spinal stenosis with osteoporotic vertebral fracture involving endplate: a retrospective study. [PDF]
Zhang Q +6 more
europepmc +1 more source
External carotid steal and lateral medullary infarction - is there a pathogenetic connection? [PDF]
A Wallenberg +18 more
core +1 more source
Osteochondrosis in horses: An overview of genetic and other factors
Abstract Osteochondrosis (OC) is a frequent manifestation of developmental orthopaedic disease, and its severe clinical presentation is known as OC dissecans (OCD). OC is defined as a disruption of the endochondral ossification process in the epiphyseal cartilage, and this disease has been reported in different mammalian species, including humans, dogs,
Lola Martinez‐Saez +2 more
wiley +1 more source
Efficacy of JOINS Tablet for Lumbar Spinal Stenosis: Prospective, Randomized, Open-Label Clinical Trial. [PDF]
Ko S, Kim H.
europepmc +1 more source

